go back

Ranibizumab (Susvimo) Sustained-Release Implant

New Jersey rates for HCPCS C9093

Injection, ranibizumab, via sustained release intravitreal implant (Susvimo), 0.1 mg

Rates data updated July 2026.

Facilitymedian $9,550 · 10th–90th $81$23,9880%20%10th90th$9,550Professionalmedian $79 · 10th–90th $66$810%50%10th90th$79$100.0$500.0$2.0K$10.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$81.28
Median
$81.28
Typical High
$81.28
Aetna
Setting
Professional
Modifier
Global
Typical Low
$66.07
Median
$79.43
Typical High
$81.28
Horizon BCBS
Setting
Facility
Modifier
Global
Typical Low
$100.00
Median
$11,481.54
Typical High
$25,118.86
Horizon BCBS
Setting
Professional
Modifier
Global
Typical Low
$81.28
Median
$81.28
Typical High
$81.28